Cyanotech Corp splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Mar 31, 2025 was Packaged Astaxanthin at $13.1 million, 54% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2025
Sep 30, 2025
|
FY 2025
Mar 31, 2025
|
FY 2024
Mar 31, 2024
|
FY 2023
Mar 31, 2023
|
FY 2022
Mar 31, 2022
|
FY 2021
Mar 31, 2021
|
FY 2020
Mar 31, 2020
|
FY 2018
Mar 31, 2019
|
FY 2018
Mar 31, 2018
|
FY 2017
Mar 31, 2017
|
FY 2016
Mar 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
24
|
24
|
23
|
23
|
36
|
32
|
32
|
30
|
34
|
32
|
32
|
| Packaged Astaxanthin |
13
-3.6%
share 53.9%
|
13
-3.4%
share 54.3%
|
14
+11.3%
share 59.0%
|
12
-18.1%
share 52.8%
|
15
+2.9%
share 41.5%
|
15
share 44.9%
|
—
|
—
|
—
|
—
|
—
|
| Packaged Spirulina |
5
+0.7%
share 21.4%
|
5
-9.6%
share 21.6%
|
6
+20.0%
share 25.0%
|
5
-36.7%
share 20.8%
|
8
-0.2%
share 21.1%
|
8
share 23.5%
|
—
|
—
|
—
|
—
|
—
|
| Bulk Astaxanthin |
4
+94.6%
share 16.1%
|
3
+73.9%
share 10.7%
|
1
-24.8%
share 6.5%
|
2
-19.0%
share 8.6%
|
2
+7.4%
share 6.8%
|
2
share 7.0%
|
—
|
—
|
—
|
—
|
—
|
| Bulk Spirulina |
3
+41.2%
share 11.1%
|
2
+53.0%
share 9.9%
|
2
-55.6%
share 6.8%
|
4
-65.9%
share 15.3%
|
10
+45.9%
share 28.9%
|
7
share 22.0%
|
—
|
—
|
—
|
—
|
—
|
| Contract Extraction And RD Services |
1
-31.0%
share 2.3%
|
1
+37.8%
share 3.5%
|
1
+0.3%
share 2.7%
|
1
+2.3%
share 2.6%
|
1
-26.7%
share 1.7%
|
1
share 2.5%
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CYAN (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Kailua Kona, HI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 768408
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.